title: A prospective study of continuous intravenous milrinone therapy for status IB patients awaiting heart transplant at home.
authors.affiliation: Department of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania 19104, USA. brozenas@uphs.upenn.edu
authors.forename: Susan C
authors.initials: SC
authors.lastname: Brozena
authors.forename: Carol
authors.initials: C
authors.lastname: Twomey
authors.forename: Lee R
authors.initials: LR
authors.lastname: Goldberg
authors.forename: Shashank S
authors.initials: SS
authors.lastname: Desai
authors.forename: Brian
authors.initials: B
authors.lastname: Drachman
authors.forename: Andrew
authors.initials: A
authors.lastname: Kao
authors.forename: Eric
authors.initials: E
authors.lastname: Popjes
authors.forename: Ross
authors.initials: R
authors.lastname: Zimmer
authors.forename: Mariell
authors.initials: M
authors.lastname: Jessup
mesh_terms: D002302:Cardiac Output; D002316:Cardiotonic Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D017147:Defibrillators, Implantable; D005240:Feasibility Studies; D005260:Female; D005500:Follow-Up Studies; D016027:Heart Transplantation; D018718:Home Infusion Therapy; D006801:Humans; D007262:Infusions, Intravenous; D008297:Male; D008875:Middle Aged; D020105:Milrinone / Q000008:administration & dosage / Q000627:therapeutic use*; D011446:Prospective Studies; D011788:Quality of Life; D012449:Safety; D013997:Time Factors; D014850:Waiting Lists
chemical_list: D002316:Cardiotonic Agents; D020105:Milrinone